Rife Technology Destroys Microbes
Rife ignored the debate, preferring to concentrate on refining his method of destroying these tiny killer viruses. He used the same principle to kill them, which made them visible: resonance. By increasing the intensity of a frequency which resonated naturally with these microbes, Rife increased their natural oscillations until they distorted and disintegrated from structural stresses. Rife called this frequency the mortal oscillatory rate, or MOR, and it did no harm whatsoever to the surrounding tissues.
This principle can be illustrated by using an intense musical note to shatter a wine glass: the molecules of the glass are already oscillating at some harmonic (multiple) of that musical note; they are in resonance with it, vibrate, and can no longer remain in configuration. Because everything else has a different resonant frequency, nothing but the glass’s molecular configuration is destroyed. There are literally hundreds of trillions of different resonant frequencies, and every species and molecule has its very own.
Testing Rife’s Treatment
It took Rife many years, working 48 hours at a time, until he discovered the frequencies which specifically destroyed herpes, polio, spinal meningitis, tetanus, influenza, and an immense number of other dangerous disease organisms. In 1934, the University of Southern California appointed a Special Medical Research Committee to bring terminal cancer patients from Pasadena County Hospital to Rife’s San Diego Laboratory and clinic for treatment. The team included doctors and pathologists assigned to examine the patients – if still alive – in 90 days. This was obviously a different age! I don’t believe I’ll be seeing the University of Minnesota bringing any patients my way anytime soon. Remember, 1934 was PRE-big-money-chemo!
After the 90 days of treatment, the Committee concluded that 86.5% of the patients had been completely cured. The treatment was then adjusted and the remaining 13.5% of the patients also responded within the next four weeks. The total recovery rate using Rife’s technology was 100%. On November 20, 1934, forty-four of the nation’s most respected medical authorities honored Royal Rife with a banquet billed as The End To All Diseases at the Pasadena estate of Dr. Milbank Johnson.
But by 1939, almost all of these distinguished doctors and scientists were denying that they had ever met Rife. What happened to make so many brilliant men have complete memory lapses? It seems that news of Rife’s miracles with terminal patients had reached other ears. Remember our hypothetical question at the beginning of this report: What would happen if you discovered a cure for everything? You are now about to find out…
The Beginning of Rife’s Downfall
At first, a token attempt was made to buy-out Rife. Morris Fishbein, who had acquired the entire stock of the American Medical Association by 1934, sent an attorney to Rife with an offer you can’t refuse. Rife refused. We may never know the exact terms of this offer, but we do know the terms of the offer Fishbein made to Harry Hoxsey for control of his herbal cancer remedy. Fishbein’s associates would receive all profits for nine years and Hoxey would receive nothing. Then, if they were satisfied that it worked, Hoxsey would begin to receive 10% of the profits. Hoxsey decided that he would rather continue to make all the profits himself. When Hoxsey turned Fishbein down, Fishbein used his immensely powerful political connections to have Hoxsey arrested 125 times in a period of 16 months. The charges (based on practicing without a license) were always thrown out of court, but the harassment drove Hoxsey insane.
Fishbein must have realized that this strategy would backfire with Rife. First, Rife could not be arrested like Hoxsey for practicing without a license since he had a license. A trial on trumped-up charges would mean that prominent medical authorities working with Rife would introduce testimony supporting Rife, and the defense would undoubtedly take the opportunity to introduce evidence such as the 1934 medical study done with USC. The last thing in the world that the pharmaceutical industry wanted was a public trial about a painless therapy that cured 100% of the terminal cancer patients and cost nothing to use but a little electricity. It might give people the idea that they didn’t need drugs and though the drug industry was in its infancy in 1934, it was becoming a very naughty teenager by 1939.
In 1939, a mysterious lawsuit against Beam Ray Corporation, the only company manufacturing Rife’s frequency instruments (Rife was not a partner) tied the company up in court and legal expenses in the middle of the Great Depression bankrupted the company. Fishbein and the AMA had won; commercial production of Rife’s frequency instruments ceased completely.
On the other hand, big money was spent ensuring that doctors who had seen Rife’s therapy would forget what they saw. Almost no price was too much to suppress it. Remember that, today, treatment of a single cancer patient averages over $300,000. It’s BIG business.
Thus, Arthur Kendall, the Director of the Northwestern School of Medicine who worked with Rife on the cancer virus, accepted almost a quarter of a million dollars to suddenly retire in Mexico. That was an exorbitant amount of money in the Depression. Dr. George Dock, another prominent figure who collaborated with Rife, was silenced with an enormous grant, along with the highest honors the AMA could bestow. Between the carrots and the sticks, everyone except Dr. Couche and Dr. Milbank Johnson gave up Rife’s work and went back to prescribing drugs.
To finish the job, the medical journals, supported almost entirely by drug company revenues and controlled by the AMA, refused to publish any paper by anyone on Rife’s therapy. Therefore, an entire generation of medical students graduated into practice without ever once hearing of Rife’s breakthroughs in medicine. The magnitude of such an insane crime eclipses every mass murder in history. Cancer picks us off quietly…but by 1960 the casualties from this tiny virus exceeded the carnage of all the wars America ever fought. In 1989, it was estimated that 40% of us will experience cancer at some time in our lives.
After Rife’s Downfall
In Rife’s lifetime, he had witnessed the progress of civilization from horse-and-buggy travel to jet planes. In that same time, he saw the epidemic of cancer increase from 1 in 24 Americans in 1905 to, partially because his work was squashed, 1 in 2.5 today.
He also witnessed the phenomenal growth of the American Cancer Society, the Salk Foundation, and many others collecting hundreds of millions of dollars for diseases that were cured long before in his own San Diego laboratories. In one period, 176,500 cancer drugs were submitted for approval. Any that showed favorable results in only one-sixth of one percent of the cases being studied could be licensed. Some of these drugs had a mortality rate of 14-17%. When death came from the drug, not the cancer, the case was recorded as a complete or partial remission because the patient didn’t actually die from the cancer. It’s just absurd!!! In reality, it was a race to see which would kill the patient first: the drug or the disease.
The inevitable conclusion reached by Rife was that his life-long labor and discoveries had not only been ignored but probably would be buried with him. At that point, he ceased to produce much of anything and spent the last third of his life seeking oblivion in alcohol. It dulled the pain and his acute awareness of half a century of wasted effort – ignored – while the unnecessary suffering of millions continued so that a vested few might profit. And profit they did, and profit they do.
Rife’s Technology Lives On
Fortunately, his death was not the end of his electronic therapy. A few humanitarian doctors and engineers reconstructed his frequency instruments and kept his genius alive. Rife technology became public knowledge again in 1986 with the publication of The Cancer Cure That Worked, by Barry Lynes, and other material about Royal Rife and his monumental work.
There is wide variation in the cost, design, and quality of the modern portable Rife frequency research instruments available. Costs vary from about $3600 to $26,000 with price being no legitimate indicator of the technical competence in the design of the instrument or performance of the instrument. Some of the most expensive units have serious technical limitations and are essentially a waste of money. At the other extreme, some researchers do get crude results from inexpensive simple, unmodified frequency generators, but this is just as misguided as spending too much money. Without the proper modifications, the basic frequency generator gives only minimal and inconsistent results. Rife’s work was always with LIGHT FREQUENCY. A REAL Rife unit must use a Tesla bulb.
Other theories abound on exactly why and how Rife technology works. Dr. Robert O. Becker, MD, in his book, The Body Electric, published by Harper in 1985, gives an exciting report in chapter 15 regarding the fact that photons in light act as an electron donor to tissue cells which stimulates mitochondrial function, raises tissue pH, and increases healing.
One day, the name of Royal Raymond Rife may ascend to its rightful place as the giant of modern medical science. Until that time, his fabulous technology remains available only to the people who have the interest to seek it out. While perfectly legal for veterinarians to use to save the lives of animals, Rife’s brilliant frequency therapy remains taboo to orthodox mainstream medicine because of the continuing threat it poses to the international pharmaceutical medical monopoly that controls the lives – and deaths – of the vast majority of the people on this planet.
Research and Studies on Rife Technology
Recent studies on Rife’s work have been published in peer-reviewed medical journals. The Journal of Exp Clinical Cancer Research 2009 Apr 14;28:51, published a paper titled, Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. The paper revealed, “CONCLUSION: Cancer-related frequencies appear to be tumor-specific and treatment with tumor-specific frequencies is feasible, well tolerated and may have biological efficacy in patients with advanced cancer.”
Their results were remarkable: “RESULTS: We examined a total of 163 patients with a diagnosis of cancer and identified a total of 1524 frequencies ranging from 0.1 Hz to 114 kHz. Most frequencies (57-92%) were specific for a single tumor type. Compassionate treatment with tumor-specific frequencies was offered to 28 patients. Three patients experienced grade 1 fatigue during or immediately after treatment. There were no NCI grade 2, 3 or 4 toxicities. Thirteen patients were evaluable for response. One patient with hormone-refractory breast cancer metastatic to the adrenal gland and bones had a complete response lasting 11 months. One patient with hormone-refractory breast cancer metastatic to liver and bones had a partial response lasting 13.5 months. Four patients had stable disease lasting for +34.1 months (thyroid cancer metastatic to lung), 5.1 months (non-small cell lung cancer), 4.1 months (pancreatic cancer metastatic to liver) and 4.0 months (leiomyosarcoma metastatic to liver).”
Many more articles are coming out on what is now being termed Energy Medicine or Biofield Therapies. Here is a list of a few:
- Cancer Journal 2006 Sep-Oct;12(5):425-31. Complementary medicine in palliative care and cancer symptom management.
- J Holist Nurs. 2011 Dec;29(4):270-8. doi: 10.1177/0898010111412186. Epub 2011 Aug 8.
- Prim Care. 2010 Mar;37(1):165-79. Biofield therapies: energy medicine and primary care.
- Ann N Y Acad Sci. 2009 Aug;1172:297-311. Bioelectromagnetic and subtle energy medicine: the interface between mind and matter.
- J Altern Complement Med. 2009 Aug;15(8):819-26. An HMO-based prospective pilot study of energy medicine for chronic headaches: whole-person outcomes point to the need for new instrumentation.
- Integr Med Insights. 2009;4:13-20. Epub 2009 Oct 19. Integral healthcare: the benefits and challenges of integrating complementary and alternative medicine with a conventional healthcare practice
- Altern Ther Health Med. 2008 Jan-Feb;14(1):44-54. Six pillars of energy medicine: clinical strengths of a complementary paradigm.
- Explore (NY). 2006 Nov-Dec;2(6):509-14. World hypotheses and the evolution of integrative medicine: combining categorical diagnoses and cause-effect interventions with whole systems research and nonvisualizable (seemingly “impossible”) healing.
- Biomed Sci Instrum. 2006;42:428-33. Localized pulsed magnetic fields for tendonitis therapy.
This was an excerpt from Dr Conners’ book, Stop Fighting Cancer and Start Treating the Cause.
Dr. Conners graduated with his doctorate from Northwestern Health Sciences University in 1986 and has been studying alternative cancer care for over 20 years. He holds AMA Fellowships in Regenerative & Functional Medicine and Integrative Cancer Therapy.
He is the author of numerous books including, Stop Fighting Cancer and Start Treating the Cause, Cancer Can’t Kill You if You’re Already Dead, Help, My Body is Killing Me, Chronic Lyme, 3 Phases of Lyme, 23 Steps to Freedom, and many more you can download for FREE on our books page.